Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Gross Margin (2022 - 2025)

HCW Biologics (HCWB) has disclosed Gross Margin for 4 consecutive years, with 20.0% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Margin changed 0.0% year-over-year to 20.0%, compared with a TTM value of 20.0% through Sep 2025, down 1241.0%, and an annual FY2024 reading of 37.38%, up 1766.0% over the prior year.
  • Gross Margin was 20.0% for Q3 2025 at HCW Biologics, roughly flat from 20.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 57.4% in Q1 2022 and bottomed at 19.08% in Q4 2023.
  • Average Gross Margin over 4 years is 27.11%, with a median of 20.0% recorded in 2024.
  • The sharpest move saw Gross Margin soared 2464bps in 2024, then crashed -3456bps in 2025.
  • Year by year, Gross Margin stood at 20.0% in 2022, then fell by -5bps to 19.08% in 2023, then grew by 5bps to 20.0% in 2024, then increased by 0bps to 20.0% in 2025.
  • Business Quant data shows Gross Margin for HCWB at 20.0% in Q3 2025, 20.0% in Q2 2025, and 20.0% in Q1 2025.